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A B S T R A C T
Skin damages have always been considered as one of the most common physical injuries. Therefore, many
researches have been conducted to find an efficient method for wound healing. Since hydrogels have suitable
characteristics, they are widely used for this purpose. In this study, based on the high efficiency of alginate and
chitosan hydrogels in the wound healing, different concentrations of hesperidin were loaded to alginate and
chitosan hydrogels followed by evaluating their morphology, swelling properties, release, weight loss, hemo-
and cytocompatibility, antibacterial and toxicity properties. Finally, the therapeutic function of the prepared
hydrogels was evaluated in the full-thickness dermal wound in a rat model. Our results indicated that the hy-
drogels have appropriate porosity (91.2 ± 5.33%) with the interconnected pores. Biodegradability of the
prepared hydrogel was confirmed with weight loss assessment (almost 80% after 14 days). Moreover, the time-
kill assay showed the antibacterial properties of hydrogels, and MTT assay revealed the positive effect of hy-
drogels on cell proliferation, and they have no toxicity effect on cells. Also, the in vivo results indicated that the
prepared hydrogels had better wound closure than the gauze-treated wound (the control group), and the highest
wound closure percentage was observed for the alginate/chitosan/10% hesperidin group. All in all, this study
shows that alginate/chitosan hydrogels loaded with 10% of hesperidin can be used to treat skin injuries in
humans.
1. Introduction
Skin, as the most significant human organ, is able to maintain the
skin integrity following injury; however, multiple factors can lead to
interrupt the wound healing [1–3]. In the United States, it has been
estimated that more than 6.5 million people suffer from chronic and
non-healing wounds, the cost of which exceeds $25 billion per year [4].
Over the last two decades, several new dressings and drug therapies
have been developed to improve normal wound healing [5,6]. Ideally,
the wound dressing should prepare a moist environment, protect the
wound from infection, and also contribute to accelerate the wound
healing process [7]. Therefore, since hydrogels provide most of the
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desirable characteristics of an ideal dressing, they have been widely
used for wound healing [8,9]. They are versatile, reducing the pain by
promoting moisture and cooling the wound surface, and also, exhibit a
wide range of mechanical properties [10,11]. They can be fabricated
from naturally occurring materials, synthetic polymers, or their hybrids
[12,13]. Using natural materials such as chitosan has many advantages
due to its biocompatibility, biodegradability, and hemostatic feature
but it has not enough flexibility leading to be easily broken into smaller
pieces [14,15]. The poor mechanical properties of chitosan could be
improved by addition of alginate, which also has the advantage of
biodegradability, biocompatibility, ability to absorb large amounts of
fluid, and as a polyanionic polymer, its carboxyl group can interact with
the amino group of chitosan [16,17]. Although hydrogels can guide the
healing process to heal the wounds, much attention is needed to sti-
mulate the proper healing of dermal wounded.
Hesperidin, flavonoids present in fruits and vegetables, have wide-
spread biological features such as anti-inflammatory, antibacterial,
antioxidant, angiogenic effects, which indicates that hesperidin may be
a therapeutical drug in skin diseases [18–20]. Several more recent de-
velopments in wound dressings have focused on the localized drug
delivery of wound healing due to the unwanted adverse effects of sys-
temic drug delivery, such as harmful side-effects into target tissues and
less predictable drug delivery to the target tissue [21–23]. Due to their
tunable physical properties such as swelling and degradability, hydro-
gels are capable of controlling the drug release rate making them a
beneficial drug delivery system for clinical use [10,11]. A previous
study showed alginate-chitosan hydrogel contributed to the accelera-
tion of wound repair due to its intrinsic antimicrobial activity [24].
Given the beneficial effect of hesperidin to improve the synthesis of
collagen, it prevents haemorrhages and infection, antioxidants, and
anti-inflammatory effects, and thus, we hypothesize that the combina-
tion of hydrogel and hesperidin could have a synergetic effect to ac-
celerate the wound healing [25,26]. To the best of our knowledge, the
effect of topical application of hesperidin-loaded hydrogel has not been
studied in wound healing studies yet. Therefore, in the present study,
the effect of different doses of hesperidin-loaded hydrogel on the
healing of skin injury in a rat model was evaluated.
2. Materials and methods
2.1. Materials
Sodium alginate (Pharmaceutical grade, molecular weight 120000),
chitosan (Pharmaceutical grade medium molecular weight 162.16),
hesperidin, penicillin, streptomycin, calcium chloride (CaCl2), and
glutaraldehyde were all purchased from Sigma-Aldrich (St. Louis, USA).
3-(4, 5-dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide (MTT),
Dulbecco's modified Eagle's medium: nutrient mixture F-12 (DMEM/
F12), and fetal bovine serum (FBS) were purchased from Gibco, BRL
(Eggenstein, Germany).
2.2. Hydrogel preparation
To prepare alginate/chitosan/hesperidin (Alg/Chit/Hes) hydrogel,
first sodium alginate (2% w/v) was dissolved in deionized water. Then
chitosan (2% w/v) was dispersed in acetic acid (0.5% v/v) and gently
stirred for 24 h at 40 °C to dissolve completely. The sodium alginate and
chitosan solutions mixed with ratio of 2:1 v/v. Next, the various con-
centrations of hesperidin (0, 1, 10% weight of polymer Alg/Chit) was
added to the Alg/Chit solution. Afterward, in order to initiate gelation,
calcium chloride 50 mM (CaCl2) and 10 μl glutaraldehyde with NaOH
1 M were added to crosslink the alginate and chitosan, respectively.
Finally, the prepared solution was mixed and vortexed for 1 h.
2.3. Lyophilization
The prepared solutions were first frozen for 16 h at −80 °C. To
prepare the porous hydrogels, the frozen gels were lyophilized using a
freeze drier (Telstar, Terrassa, Spain) for 48 h at −54 °C.
2.4. Hydrogel characterization
2.4.1. Morphological properties
The sample was freeze-dried, and the dry sample cut in the diameter
of 7 mm. The ultrastructure of Alg/Chit/1%Hes gel was analyzed by
scanning electron microscope (SEM AIS2100, Seron Technology, South
Korea) after sputter coating with gold for 250 s by a sputter coater
(SC7620, Quorum Technologies, England) at an accelerating voltage of
20 kV. The average diameters of pores were statistically calculated by
using the Image J (National Institutes of Health, Bethesda, USA) and
Origin Pro 2015 software (Origin Lab, Northampton, USA) by analyzing
a total of 20 random points per image.
2.4.2. Swelling studies
It is well-established that the swelling behavior should be con-
sidered when biodegradable materials for drug delivery applications
are evaluated [27]. The phosphate-buffered saline (PBS) solution
(pH = 7.4), at ambient temperature, was used to evaluate the swelling
behavior of Alg/Chit hydrogels, and Equation (1) was used to calculate
its amount [28]:
= − ×m m
m
Equilibrium mass swelling 1001 0
0 (1)
where m0 is the dried mass and m1 is the swollen mass of the hydrogel.
The Alg/Chit hydrogel was lyophilized by using a freeze drier until a
constant weight of the gel was reached. Then, a specific amount of
hydrogel (4 ml) was immersed in 20 ml of PBS and kept at room
temperature for three days. During that period and at the specific time
intervals, the specimens were removed from the PBS and quickly
weighed. The measurements were performed, and equilibrium mass
swelling percentages were calculated from the abovementioned equa-
tion.
2.4.3. Weight loss analysis
The degradation rate of the prepared hydrogels was evaluated from
their mass loss. Therefore, each dried hydrogel disk was weighed, and
equal-weight samples were placed in a falcon tube containing PBS at
37 °C, and the weight loss measurement was performed at 7 and 14
days. At indicated time intervals, triplicate specimens for each group
were taken out and dried. Equation (2) was used to determine the de-
gree of degradation in which W0 is the primary weight of hydrogels and
W1 is the dry weight after removal from water [29].
= − ×W W
W
Weight loss % 0 1
0
100 (2)
2.4.4. Release of hesperidin
The UV–visible spectroscopy was used to evaluate the release of
hesperidin from Alg/Chit hydrogel. Alg/Chit/Hes hydrogels (1 mL)
were loaded in simulated body fluid (SBF) (5 mL), and the samples were
shaken in an incubator shaker under 37 °C at 40 rpm. At various time
intervals, the supernatants were extracted and centrifuged, and to de-
termine the amount of released hesperidin, the absorption intensity of
supernatants was recorded at 285 nm [30].
2.4.5. Blood compatibility
In this test, 2 ml of human fresh anticoagulated blood diluted with
2.5 ml of normal saline. Next, 0.2 ml of the diluted blood was added to
the samples. The mixture worked for 60 min at 37 °C, and then the
samples were centrifuged at 1500 rpm for 10 min. The created
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supernatants were transferred to a 96-well plate, and the Anthos 2020
(Biochrom, Berlin, Germany) microplate reader was used to measure
the absorbance of samples at 545 nm.
In this test, the negative control was 0.2 ml diluted blood in 10 ml
normal saline, while the positive control consisted of 0.2 ml diluted
blood in 10 ml deionized water. Eventually, hemolysis degree was







where Dt is the absorbance of the sample, Dnc is the absorbance of the
negative control, and Dpc is the absorbance of the positive control.
2.4.6. Antibacterial assay
The antibacterial properties of the prepared hydrogels against two
bacterial species (Staphylococcus aureus and Pseudomonas aeruginosa)
were analyzed by a time-kill assay based on the previous studies
[32–34]. Briefly, a bacterial suspension was adjusted to 1 × 107 CFU/
ml. The hydrogels were added to the suspension at concentrations of 1/
2-fold of the minimum inhibition concentrations (MIC). The suspension
(0.5 mL) was incubated at 37 °C with gentle agitation in a shaking water
bath. After 24 h of incubation, 10 μL of the suspension was serially-
diluted and inoculated on agar plates. After 1, 2, 4, and 24 h of aerobic
incubation at 37 °C, the number of viable bacteria colonies was
counted. The bacterial growth assays were done in triplicates.
2.5. Cell viability studies
The MTT assay was used to quantitatively assess the viability of cells
cultured into the hydrogels. 3T3 murine fibroblast cell line was cultured
at the density of 1 × 104 cells on hydrogel in DMEM/F12 supplemented
with 10% (v/v) FBS, 100 unit/ml of penicillin and 100 μg/ml of
streptomycin in a humidified incubator at 37 °C with 5% CO2. 1 and 3
days after cells seeding, the culture medium was removed from the 96-
well plate and 150 μl of MTT (0.5 mg/ml) was added to each well.
Afterward, the cells were incubated at 37 ̊C for 3–4 h in a dark place,
and then, the solution was removed, and 0.1 ml DMSO was added to
each well. The formed purple formazan crystals were dissolved in
DMSO, and the absorption was measured at a wavelength of 570 nm
utilizing a microplate reader Anthos 2020 (Biochrom, Berlin,
Germany). The positive control was the cells cultured on the tissue
culture plate (TCP). All experiments were repeated three times.
2.6. In vivo wound healing study
A full-thickness excisional wound model was used to evaluate the
ability of the hydrogels with and without hesperidin in wound healing.
Thirty healthy adult male Wistar rats (200–220 g) of 2 months of age
were purchased from Pasteur Institute (Tehran, Iran). Animal experi-
ments were approved by the ethics committee of the Iran University of
Medical Sciences (ethical code: IR.IUMS.REC.1398.432) and were car-
ried out in accordance with the university's guidelines. Moreover, all
animal experiments comply with the National Institutes of Health guide
for the care and use of laboratory animals (NIH Publications No. 8023,
revised 1978). General anesthesia was induced by intraperitoneal in-
jection of the mixture of ketamine (Alfasan, Woerden, The Netherlands;
100 mg/1 kg body weight) and xylazine (Alfasan, Woerden, The
Netherlands; 10 mg/1 kg body weight). Afterward, a 1.50 × 1.50 cm2
full-thickness wound was excised using a scalpel blade on the back skin
of rats near the neck posterior surface. The animals were then randomly
divided into five groups (6 rats in each group), and the wounds were
treated with alginate/chitosan hydrogel without hesperidin, alginate/
chitosan/1% hesperidin, alginate/chitosan/10% hesperidin, and sterile
gauze as the negative control. The hydrogels were then embedded on
the injury site using an elastic adhesive bandage.
A digital camera (Canon Inc., Tokyo, Japan) at the 7- and 14-days
post-surgery was used to evaluate the rate of wound closure by re-
cording the reduction of the wound size. The image analyzing program
(Digimizer, Ostend, Belgium) was used to measure the wound area.













Six animals from each group were euthanized 14 days post-treat-
ment, and the skin tissues were harvested and immediately fixed in the
10% neutral buffered formalin (PH. 7.26) for 48 h. Then the fixed tissue
samples processed, embedded in paraffin, and sectioned to 5 μm
thickness. Finally, the sections were stained with hematoxylin and eosin
(H&E) and Masson's trichrome (MT). The histological slides were
evaluated by the independent reviewer, using light microscopy
(Olympus BX51; Olympus, Tokyo, Japan). Epithelialization, angiogen-
esis, fibroplasia, and granulation tissue formation were assessed in
different groups, comparatively.
2.6.2. Histomorphometry analysis
Epithelialization on day 14 was assessed in respect of angiogenesis,
and it was scored according to the number of new vessels within the
tissue (Figs. 5 and 6), using a 5-point scale as follows: 0 (none), 1 (few),
2 (moderate), 3 (many) or 4. The results of these parameters were re-
ported by a comparative analysis of one independent observer who was
blind to the treatment groups.
2.7. Statistical analysis
The Origin Pro software (Version9, OriginLab, Northampton, MA)
using a statistic on rows and two‐sample t-test on rows was used to
statistically analyze the results, and the data were expressed as a




The SEM image was used to microscopically observe the mor-
phology of Alg/Chit/1%Hes hydrogel and evaluate its microstructure
(Fig. 1). The SEM image revealed that the prepared hydrogel had a
highly porous structure comprised of interconnected pores. The por-
osity of Alg/Chit/1%Hes hydrogel was calculated as 91.2 ± 5.33%.
Fig. 1. Scanning electron microscopy of Alg/Chit/1%Hes.
Z. Bagher, et al. Journal of Drug Delivery Science and Technology 55 (2020) 101379
3
The pore size was in the range of 63–144 μm, which is favorable for the
cell attachment and migration [36].
3.2. Swelling behavior and weight loss
The swelling behavior of Alg/Chit hydrogel cross-linked with cal-
cium chloride and glutaraldehyde was evaluated from their water up-
take value, and the results are shown in Fig. 2A. The interactions be-
tween Alg/Chit chains and water molecules could cause the polymer to
be swelled while the cross-linking protects the polymer from dissolu-
tion. The swelling of Alg/Chit hydrogel provides an appropriate 3D
structure that mimics the native microenvironment of cells and sup-
ports cell survival, proliferation, and migration. The results show that
the highest swelling percentage was 344 ± 12% at 240 min after the
incubation. The previous study showed that swelling rate is important
to obtain a sustained drug delivery in the wound healing site [37].
The degradation rate of the wound dressing should be matched with
the healing rate of the wound. The slow degradation rate hinders
wound dresser replacement with the formed tissue. On the other hand,
the fast degradation rate might leave the wound site empty, and sub-
sequently, abort the wound healing process. The results of the weight
loss for the prepared hydrogels are reported in Fig. 2B. One could infer
that the weight loss rate increases to almost 80% upon rising the
amount of hesperidin.
3.3. Release
The cumulative release profile of hesperidin is shown in Fig. 2C. It
was found that 8.9 ± 1.49% and 17.2 ± 3.67% of the hesperidin has
been released within the first 3 and 6 h, respectively, followed by a
sustained release of 77.03 ± 8.71% over 14 days.
3.4. Hemocompatibility results
The compatibility of the prepared wound dresser with blood cells,
especially erythrocytes, is regarded as a prerequisite for the wound
healing [38]. The interaction of the wound dresser with erythrocytes is
an initial phase phenomenon after the wound dresser implantation,
which determines the following body reactions such as inflammation.
The compatibility assay was performed with the interaction between
the prepared Alg/Chit with and without hesperidin and fresh ery-
throcytes which were collected from a healthy volunteer and the re-
leased hemoglobin was quantified with a microplate reader. As shown
in Fig. 3A, the hemolysis induced by the prepared Alg/Chit hydrogel
and Alg/Chit hydrogel with different amounts of hesperidin are sig-
nificantly lower than positive control, implying the hemocompatibility
of the prepared hydrogels.
3.5. Antibacterial properties of the wound dressing
The results of the antibacterial growth assay are reported in Table 1.
It was demonstrated that Alg/Chit hydrogel group had a lower number
of colonies with regard to the group without wound dressing. By adding
hesperidin to the wound dressing, the number of colonies was sig-
nificantly decreased, and the number of colonies in Alg/Chit/10%Hes
group is significantly lower than Alg/Chit/1%Hes group. It was
indicated that the Lag growth phase of the two bacteria studied in the
Alg/Chit/10%Hes sample was significantly longer than that of the
control and Alg/Chit/1%Hes samples.
3.6. Cytotoxicity results
Cytotoxicity of the prepared hydrogels was evaluated using the MTT
assay kit at 24 and 72 h after cell seeding, and the results are shown in
Fig. 3B. The results reveal that the prepared hydrogels are not only
cytocompatible but also have a proliferative effect on the growth of the
cells. In Fig. 3B, the positive effect of hesperidin is shown on 3T3
murine fibroblast growth at both incubation times. The cell prolifera-
tion on the Alg/Chit/Hes hydrogel is statistically significant compared
with TCP at 24 h. It is even significantly higher than Alg/Chit hydrogel
72 h after cell seeding. In addition, by increasing the amount of he-
speridin, cell proliferation increases as well. These results suggest that
the incorporation of hesperidin into the Alg/Chit hydrogel has made
them more suitable for cell proliferation due to its tremendous positive
effect on cell growth.
3.7. In vivo wound healing study
Fig. 4 demonstrates the healing effects of the Alg/Chit hydrogel
without and with different concentrations of hesperidin as the wound
dressings. Fig. 4A shows the macroscopic appearance of wound sites
that were covered with a commercial wound dressing (sterile gauze)
and Alg/Chit hydrogel without and with different amounts of hesper-
idin. The image showed that the wound site of Alg/Chit hydrogel group
had infection and inflammation, and the healing was incomplete. On
the other hand, the groups containing hesperidin treated better rather
than the control and Alg/Chit hydrogel groups. Overall, the best per-
formance was observed in the case of Alg/Chit/10%Hes. The image
provides that the wound site had no sign of infection and inflammation,
and the wound treated very well.
To quantify the wound-healing process wound closure was de-
termined (Fig. 4B). The wound closure of commercial wound dressing
was 32 ± 1.66% and 59.1 ± 2.6% after 7- and 14-days post-surgery,
respectively. The wound closure of Alg/Chit hydrogel group after 7 and
14 days of surgery was 51 ± 4.38%, 67.8 ± 0.5%, respectively. By
adding hesperidin to the prepared hydrogel, the best results were at-
tained for Alg/Chit/10%Hes for which the wound closure was
82 ± 4.2% and 98 ± 1.87% at 7 and 14 days after wounding, re-
spectively.
3.8. Histopathological results
Histologic sections of normal skin tissue were shown in Fig. 5 (A, B,
and C). Histopathological evaluation of the negative control group re-
vealed a considerable degenerated neutrophils and eosinophils in-
filtration. Moreover, the defect site is almost empty, and it covered only
by a crusty scab (Fig. 5. E& F-asteroid). Hydrogel without hesperidin
showed the initiation of epidermal formation in the defect site. The
wound was almost covered with an epidermal layer, and the granula-
tion tissue was evident underneath the new epidermal layer (Fig. 5. I-
thick arrow). Histopathology of hydrogel with 1% hesperidin-treated
wounds displayed granulation tissue (GT) formation and epidermal
Fig. 2. (A) The swelling percentages of the
Alg/Chit hydrogel in PBS at ambient tem-
perature over time, (B) Weight loss percen-
tage of different prepared hydrogels in PBS
at 37 °C at different time points (7 and 14
days), (C) Cumulative release profile of he-
speridin from the Alg/Chit hydrogel in SBF
at 37 °C. Values represent the mean ± SD,
n = 3.
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proliferation (Fig. 5. L-thick arrow). Hydrogel with 10% hesperidin-
tread groups showed wound contraction, epidermal layer formation
and remodeling (Fig. 5. O-thick arrow). Although the epidermal layer
was completely formed in this group, the hair follicles and appendages
(sebaceous gland, etc.) were still absent in this treatment group.
The results of MT staining (Fig. 6) illustrated that among the ex-
perimental groups, the hydrogel with 10% hesperidin exhibited a better
collagen synthesis and deposition during the wound treatment period.
On the other hand, the rate of collagen fiber synthesis and deposition in
wounds was the lowest in the case of control negative and hydrogel
without hesperidin groups, respectively. It could be inferred that the
rate of collagen synthesis was enhanced by increasing the percentage of
hesperidin.
3.9. Histomorphometric analysis
The results of histomorphometric analysis after 14 days of skin in-
jury are presented in Table 2. Amongst all groups, re-epithelialization in
the negative control group was the minimum, and the group treated
with 10% hesperidin showed the highest epidermal proliferation and
remodeling (P < 0.01). Neovascularization for hesperidin 10% group
was significantly higher than other experimental groups (P < 0.05).
Overall, the healing condition of the hesperidin 10% treated group was
better than the hesperidin 1%, Alg/Chit hydrogel, and negative control
group on day 14. However, the range of wound healing was moderate
in comparison with the positive control group.
4. Discussion
Healing deep wounds becomes a major challenge for wound care
specialists. Therefore, specialized therapy is needed to promote proper
healing of deep dermal wounded tissues [39,40]. This study aimed to
evaluate the combinatorial effects of hydrogel and hesperidin on skin
wound healing. To clarify this issue, Alg/Chit hydrogel was prepared
and characterized, and then loaded with different amounts of hesper-
idin, and eventually, the prepared wound dressing was placed in rats
after dorsal skin injury. Morphological and functional assessments were
used to evaluate the effect of hydrogel and hesperidin on the recovery
rate of the injured animals. Different studies have attempted to design
and fabricate a practical wound dresser that can not only enhance
wound healing but also can accelerate this process [41,42]. Because of
their appropriate properties, such as the ability to cool the wound site
and having a good structure for cell migration, adhesion, and growth,
hydrogels are being widely used in wound healing [43,44]. The com-
posite hydrogels exhibited multiple superiorities which could positively
influence the wound healing. Alginate hydrogel has been widely used in
wound healing because of its hemostatic ability [45]. Moreover, it has
been identified as a substrate for cell proliferation [46,47]. On the other
hand, because of its suitable properties like non-toxicity, stability,
biodegradability, and biocompatibility, chitosan is a suitable candidate
for wound healing applications. Moreover, chitosan hydrogel structures
can be loaded with various types of drugs in different physical forms
[43]. By using both alginate and chitosan, the hydrogel has excellent
gel-forming properties leading to a promising performance in biome-
dically-relevant hydrogel systems [48].
Hydrogel has a porous structure that can improve cell attachment
and migration. Moreover, the interconnected structure could enhance
gaseous exchange and provide the passage for nutrients through the
diffusion mechanism [49]. The pore size in the range of 20–120 μm has
been considered as an appropriate range for the wound healing process
[50]. In our study, the average pore size was obtained in the range of
63–144 μm, which was appropriate for cell attachment and migration
[36].
Polymers with the ability to form hydrogels have hydrophilic or
hydrophobic functional groups. Hydrophilic functional groups provide
the ability to absorb water leading to hydrogel expansion; this ability is
known as swelling [51]. A previous study indicated that once the
swelling process begins, the pore size increases and the structure be-
comes more suitable for cell attachment and growth [52]. As hesperidin
located between Alg/Chit chain and the Alg/Chit hydrogel cannot resist
for a long time, it affects swelling, weight loss, and also the release of
the prepared hydrogel. The results confirmed this claim and indicated
that by increasing the amount of loaded hesperidin, the amount of
weight loss increases too.
Fig. 3. (A) Blood compatibility histogram of prepared hydrogels, (B) MTT assay histogram after 24 and 72 h post cell seeding, Values represent the mean ± SD,
n = 3, *p < .05, **p < .01, and ***p < .001. SD: standard deviation.
Table 1
Antimicrobial activity of Alg/Chit hydrogel with different amounts of hesperidin (number of colony forming unit). S.U: Staphylococcus aureus PS.a: Pseudomonas
aeruginosa. Values represent the mean ± SD, n = 3.
Groups S.U-0h S.U-1h S.U-2h S.U-4h S.U-24 h PS.a-0h PS.a-1h PS.a-2h PS.a-4h PS.a-24 h
Without Wound Dressing 11 ± 0.5 26 ± 1.4 77 ± 1.9 187 ± 3.9 449 ± 5.6 10 ± 1.2 30 ± 2.9 50 ± 2.6 165 ± 3.2 497 ± 9.3
Alg/Chit Hydrogel 12 ± 1.2 26 ± 8.09 73 ± 4.6 159 ± 9.1 415 ± 12.8 11 ± 0.4 23 ± 2.5 29 ± 3.1 109 ± 5.1 355 ± 7.8
Alg/Chit/1%Hes 11 ± 1 19 ± 1.5 58 ± 4.9 125 ± 3.2 401 ± 3.8 12 ± 0.9 20 ± 1.4 27 ± 1.8 77 ± 2.3 299 ± 7.3
Alg/Chit/10%Hes 12 ± 0.8 15 ± 2.7 40 ± 3.3 59 ± 3.7 245 ± 2.7 10 ± 1 15 ± 1.8 19 ± 2.9 50 ± 5.2 128 ± 9.3
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Hemolysis shows the amount of hemoglobin released into the
plasma because of damage in erythrocytes. A previous study believes
that the hemolysis rate is directly related to the blood compatibility of
different materials [39]. In the current study, the hemolysis rate of the
Chit/Alg hydrogel with different amounts of hesperidin was the same,
and less than the positive control. Therefore, it was found that the
hemolysis rate did not change as a result of adding hesperidin to the
prepared hydrogel. There is a large body of evidence showing the effect
of hesperidin as an anti-inflammatory, antibacterial, antioxidant, anti-
radical, diuretic, antiulcer, and antiviral drug implying its decisive role
for promoting the healing of excision wounds [19,53–55]. Hesperidin
has also been found to improve the strength of capillary, preventing
haemorrhages and alleviates infections [56,57]. Experimental data
have shown that angiogenesis plays an essential part in the process of
wound healing. Haddadi et al. showed hesperidin could stimulate epi-
thelialization, collagen deposition, and cellular proliferation through
inducing the VEGF gene, and thus, showed the therapeutic role in im-
proving the wound repair [58].
In this study, the results of the MTT assay showed that hesperidin
could increase cell proliferation. Furthermore, the Alg/Chit/10%Hes
had the highest cell proliferation between other groups, demonstrating
the positive effect of hesperidin. Moreover, the results confirmed that
the prepared hydrogel imposed no cytotoxicity effect on the cells.
In vivo study was used to evaluate the effect of a prepared hydrogel
loaded with different amounts of hesperidin on wound healing. The
macroscopic evaluation was used, and the results indicated that Alg/
Chit/10%Hes had 82 ± 4.2% and 98 ± 1.87% wound healing in 7
and 14 days after surgery which was more than other groups. For fur-
ther investigation, histopathological and histomorphometric analysis
were also used showing that Alg/Chit/10%Hes has better wound
Fig. 4. In vivo wound-healing results: (A) macroscopic appearances of wounds treated 7- and 14-days post-wounding, (B) histogram comparing the wound closure
7th and 14th days post wounding. Values represent the mean ± SD, n = 6, *p < .05, **p < .01, and ***p < .001. SD: standard deviation.
Fig. 5. H&E stained microscopic sections of healed incisions in rats at 14 days. Fig. 6. MT stained microscopic sections of healed incisions in rats at 14 days.
Table 2
Histomorphometric analysis of different experimental groups. Values represent
the mean ± SD, n = 6.
Group Angiogenesis Score Epitheliogenesis Score
(Mean ± SD) (Mean ± SD)
Negative Control 1.3 ± 0.72 0.23 ± 0.39
Alg/Chit Hydrogel 0.33 ± 0.57 1.40 ± 0.55
Alg/Chit/1% Hes 1.33 ± 0.35 2.66 ± 0.57
Alg/Chit/10% Hes 3.61 ± 1.06 3.45 ± 1.02
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healing than other groups. Several mechanisms have been suggested to
explicate the effect of hesperidin on wound healing, namely, scavenging
free radicals, suppressing the activation of proinflammatory cytokines
such as IL-1β, IL-8, and TNF-α, increasing the capacity of fibroblast, and
endothelial cell division which are essential for tissue regeneration of
wound [55,59,60]. All in all, the attained results in this study demon-
strated the promising potential of Alg/Chit hydrogels loaded with he-
speridin for the treatment of skin injuries in clinical conditions.
5. Conclusion
In this study, the effect of Alg/Chit hydrogel with different amounts
of hesperidin on the skin wound healing in rat models was evaluated.
The results indicated that the prepared hydrogel exhibits appropriate
properties for wound healing applications. Besides, in vitro cell growth
study confirmed that the cells in the Alg/Chit/Hes groups, especially in
the group containing 10% of hesperidin had high cell proliferation ra-
ther than the control group. Furthermore, the in vitro evaluation results
showed that the Alg/Chit/10%Hes was better than other groups, and
almost 95% of the wound was healed after 14 days. The findings of this
research suggest that the prepared Alg/Chit/Hes hydrogel-based wound
dressings are promising for successful wound treatment.
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